Atherogenic potential of human blood: basic research and development of novel antiatherosclerotic therapy

Page 57 of 69

Long-term treatment by allicor let to considerable decrease of serum atherogenicity. The effect was observed during months and years of treatment.

© 2013 Institute for Aterosclerosis Research
It is forbidden to use website material without the consent of the authors and backward links.